For the quarter ending 2026-03-31, CPHI had -$176,638 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Depreciation and amortization | - | 497,425 | 356,034 | 650,176 |
| Depreciation of right of use assets | - | 75,534 | - | - |
| Accounts written off to allowance for credit losses | - | -13,664,945 | - | - |
| Financial expense | - | -3,472 | - | - |
| Credit (gains) loss | - | -27,029 | 25,302 | 709 |
| Net loss | -1,143,148 | -1,222,135 | -651,482 | -1,313,939 |
| Depreciation and amortization | 980,570 | - | - | - |
| Reversal of credit losses | 2,881 | - | - | - |
| Inventory write off | - | - | 83,947 | 422,932 |
| Provision to write down inventories to net realizable value | - | -549,218 | - | - |
| Loss on disposal of property, plant and equipment | -1,446 | - | - | - |
| Trade accounts and other receivables | 14,019 | -13,511,142 | 117,491 | 185,236 |
| Advances to suppliers | -2,546 | -17,011 | 18,697 | -10,020 |
| Inventories | -247,492 | -210,551 | -57,779 | -321,431 |
| Other payables and accrued expenses | - | 432,777 | -68,702 | 101,678 |
| Trade accounts payable | -67,771 | 292,259 | 54,437 | 303,613 |
| Other payables and accrued expenses | -14,258 | - | - | - |
| Advances from customers | -51,376 | -96,279 | 127,734 | -84,899 |
| Prepaid expenses | -6,107 | 5,802 | 178 | -6,773 |
| Net cash used in operating activities | -55,292 | 151,990 | -236,987 | 233,258 |
| Purchases of property, plant and equipment, net | - | 454 | 611 | 58,259 |
| Advances for intangible assets | - | 5,313 | 39,987 | 32,627 |
| Net cash used in investing activities | - | -5,767 | -40,598 | -90,886 |
| Payments of line of credit | 79,325 | 701,411 | -617,961 | 1,092,893 |
| Proceeds from lines of credit | - | 3,997 | - | 695,999 |
| Proceeds from related party | - | 7,573 | -44,176 | 297,673 |
| Principal payments on finance lease liabilities | - | 78,750 | - | - |
| Net cash used in financing activities | -79,325 | -72,592 | -122,214 | -99,221 |
| Effect of exchange rate changes on cash | -42,021 | 3,856 | 42,392 | -44,998 |
| Net increase in cash and cash equivalents | -176,638 | 77,487 | -357,407 | -1,847 |
| Cash and cash equivalents at beginning of period | 345,112 | 267,625 | 626,879 | - |
| Cash and cash equivalents at end of period | 168,474 | 345,112 | 267,625 | - |
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)